Indie Semiconductor Inc Ordinary Shares - Class A INDI 深 滬
已收盤 09-26 16:00:00 美东时间
4.02
+0.090
+2.29%
華盛通- 最 高4.07
- 今 開3.90
- 成交量 268.04万股
- 最 低 3.84
- 昨 收 3.93
- 總市值 8.00亿
- 52周最高 5.57
- 市盈率 靜 --
- 換手率 1.35%
- 52周最低 1.53
- 委 比 40.19%
- 總股本 1.99亿
- 歷史最高 16.33
- 量 比 0.48
- 振 幅 5.85%
- 歷史最低 1.53
- 每 手 1
- 風險率 1.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor In the Phase 3 EMBER-3 trial, Inluriyo ...
09-26 02:01
Eli Lilly Plans To Build New $6.5B Manufacturing Facility At Generation Park In Houston, Texas
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines Company plans to create 4,615 manufacturing and
09-24 01:01
India Glycols Announces Dividend Post Share Split
India Glycols Limited ( ($IN:INDIAGLYCO) ) just unveiled an update. India Glyco...
09-22 20:52
Where Neurocrine Biosciences Stands With Analysts
14 analysts have shared their evaluations of Neurocrine Biosciences (NASDAQ:NBI...
09-22 20:02
3M India Urges Shareholders to Update KYC for Dividend Payments
3M India Limited ( ($IN:3MINDIA) ) just unveiled an update. 3M India Limited ha...
09-18 16:54
Eli Lilly To Build A $5B Manufacturing Facility Just West Of Richmond, Virginia, In Goochland County; New Site Will Develop Active Pharmaceutical Ingredients In The U.S. For Cancer, Autoimmune And Other Advanced Therapies
INDIANAPOLIS, Sept. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. The new site
09-16 22:34
Lilly to participate in Bernstein's 2nd Annual Healthcare Forum
INDIANAPOLIS, Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025. Lucas Montarce, executiv...
09-11 22:00
Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views
Providing a diverse range of perspectives from bullish to bearish, 12 analysts ...
09-05 21:01
Eli Lilly's Olomorasib + KEYTRUDA Combo Secures FDA Breakthrough Therapy Designation For KRAS G12C NSCLC With High PD-L1
The Breakthrough Therapy designation for olomorasib is based on data from the Phase 1/2 LOXO-RAS-20001 trial and Phase 3 SUNRAY-01 trialUpdated efficacy and safety data for olomorasib will be presented at the IASLC 2025
09-04 18:50
Indigo Paints Concludes 25th AGM with Voting Results
Indigo Paints Ltd ( ($IN:INDIGOPNTS) ) has provided an announcement. Indigo Pai...
09-01 23:44
